Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, et al. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.J Infect Public Health. 2023;16:531–41. [DOI] [PubMed] [PMC]
Beeson A, Styczynski A, Hutson CL, Whitehill F, Angelo KM, Minhaj FS, et al. Mpox respiratory transmission: the state of the evidence.Lancet Microbe. 2023;4:e277–83. [DOI] [PubMed] [PMC]
Richard M, Knauf S, Lawrence P, Mather AE, Munster VJ, Müller MA, et al. Factors determining human-to-human transmissibility of zoonotic pathogens via contact.Curr Opin Virol. 2017;22:7–12. [DOI] [PubMed] [PMC]
Zinnah MA, Uddin MB, Hasan T, Das S, Khatun F, Hasan MH, et al. The Re-Emergence of Mpox: Old Illness, Modern Challenges.Biomedicines. 2024;12:1457. [DOI] [PubMed] [PMC]
Hossain A, Monem MA, Rahman M, Raza R. Mpox (monkeypox): a comprehensive updated of current epidemic evidence.Sci One Health. 2025;4:100100. [DOI] [PubMed] [PMC]
Sah R, Apostolopoulos V, Mehta R, Rohilla R, Sah S, Mohanty A, et al. Mpox strikes once more in 2024: Declared again as a public health emergency of international concern.Travel Med Infect Dis. 2024;61:102753. [DOI] [PubMed]
Masirika LM, Udahemuka JC, Ndishimye P, Martinez GS, Kelvin P, Nadine MB, et al. Epidemiology, clinical characteristics, and transmission patterns of a novel Mpox (Monkeypox) outbreak in eastern Democratic Republic of the Congo (DRC): an observational, cross-sectional cohort study.medRxiv 2024.03.05.24303395 [Preprint]. 2024 [cited 2025 Aug 5]. Available from: https://doi.org/10.1101/2024.03.05.24303395
Bangwen E, Diavita R, De Vos E, Vakaniaki EH, Nundu SS, Mutombo A, et al. Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010–23.Lancet. 2025;405:408–19. [DOI] [PubMed]
Rabaan AA, Alasiri NA, Aljeldah M, Alshukairiis AN, AlMusa Z, Alfouzan WA, et al. An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity.Biomedicines. 2023;11:1832. [DOI] [PubMed] [PMC]
Smith GL, Benfield CTO, Maluquer de Motes C, Mazzon M, Ember SWJ, Ferguson BJ, et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity.J Gen Virol. 2013;94:2367–92. [DOI] [PubMed]
Saghazadeh A, Rezaei N. Insights on Mpox virus infection immunopathogenesis.Rev Med Virol. 2023;33:e2426. [DOI] [PubMed]
Ganesan A, Arunagiri T, Mani S, Kumaran VR, Kannaiah KP, Chanduluru HK. From pox to protection: understanding Monkeypox pathophysiology and immune resilience.Trop Med Health. 2025;53:33. [DOI] [PubMed] [PMC]
Cambaza EM. A Review of the Molecular Understanding of the Mpox Virus (MPXV): Genomics, Immune Evasion, and Therapeutic Targets.Zoonotic Dis. 2025;5:3. [DOI]
Luna N, Ramírez AL, Muñoz M, Ballesteros N, Patiño LH, Castañeda SA, et al. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: Emergence of a novel viral lineage?Travel Med Infect Dis. 2022;49:102402. [DOI] [PubMed] [PMC]
Young B, Seifert SN, Lawson C, Koehler H. Exploring the genomic basis of Mpox virus-host transmission and pathogenesis.mSphere. 2024;9:e00576-24. [DOI] [PubMed] [PMC]
Scarpa F, Azzena I, Ciccozzi A, Branda F, Locci C, Perra M, et al. Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1.Microorganisms. 2024;12:1874. [DOI] [PubMed] [PMC]
Pekar JE, Wang Y, Wang JC, Shao Y, Taki F, Forgione LA, et al. Transmission dynamics of the 2022 mpox epidemic in New York City.Nat Med. 2025;31:1464–73. [DOI] [PubMed] [PMC]
Brüssow H. Monkeypox Virus: WHO’s Second Public Health Emergency of International Concern Within 2 Years.Microb Biotechnol. 2025;18:e70142. [DOI] [PubMed] [PMC]
Breban R. The Peculiar Emergence of Mpox (Monkeypox): Directions for the Search for the Natural Reservoir and Vaccination Strategies.Vaccines (Basel). 2024;12:1142. [DOI] [PubMed] [PMC]
Amer F, Khalil HES, Elahmady M, ElBadawy NE, Zahran WA, Abdelnasser M, et al. Mpox: Risks and approaches to prevention.J Infect Public Health. 2023;16:901–10. [DOI] [PubMed] [PMC]
Ugwu CLJ, Bragazzi NL, Wu J, Kong JD, Asgary A, Orbinski J, et al. Risk factors associated with human Mpox infection: a systematic review and meta-analysis.BMJ Glob Health. 2025;10:e016937. [DOI] [PubMed] [PMC]
Cimini E, Tartaglia E, Messina F, Coppola A, Mazzotta V, Tempestilli M, et al. Vδ2 T-cells response in people with Mpox infection: a three-month longitudinal assessment.Emerg Microbes Infect. 2025;14:2455585. [DOI] [PubMed] [PMC]
Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines.J Allergy Clin Immunol. 2010;125:S53–72. [DOI] [PubMed]
Silva MST, Coutinho C, Torres TS, Peixoto EM, Bastos MO, Mesquita MB, et al.; INI-Fiocruz Mpox Study Group. Mpox severity and associated hospitalizations among people with HIV and related immunosuppression in Brazil.AIDS. 2024;38:105–13. [DOI] [PubMed] [PMC]
Shabil M, Gaidhane S, Roopashree R, Kaur M, Srivastava M, Barwal A, et al. Association of HIV infection and hospitalization among mpox cases: a systematic review and meta-analysis.BMC Infect Dis. 2025;25:102. [DOI] [PubMed] [PMC]
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, et al.; SHARE-NET writing group. Mpox in people with advanced HIV infection: a global case series.Lancet. 2023;401:939–49. [DOI] [PubMed]
Acharya A, Kumar N, Singh K, Byrareddy SN. “Mpox in MSM: Tackling stigma, minimizing risk factors, exploring pathogenesis, and treatment approaches”.Biomed J. 2025;48:100746. [DOI] [PubMed] [PMC]
Hazra A, Cherabie JN. Is Mpox a Sexually Transmitted Infection? Why Narrowing the Scope of This Disease May Be Harmful.Clin Infect Dis. 2023;76:1504–7. [DOI] [PubMed]
Vakaniaki EH, Kacita C, Kinganda-Lusamaki E, O’Toole Á, Wawina-Bokalanga T, Mukadi-Bamuleka D, et al. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo.Nat Med. 2024;30:2791–5. [DOI] [PubMed] [PMC]
Parnian R, Heydarifard F, Mousavi FS, Heydarifard Z, Zandi M. Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape.J Innate Immun. 2024;16:413–24. [DOI] [PubMed] [PMC]
Snyder RE, Saadeh K, Tang EC, Johnson KA, Holland SN, Quint J, et al. Sexual Exposures Associated With Mpox Infection: California, November 2022 to June 2023.J Infect Dis. 2024;229:S188–96. [DOI] [PubMed] [PMC]
Falendysz EA, Lopera JG, Rocke TE, Osorio JE. Monkeypox Virus in Animals: Current Knowledge of Viral Transmission and Pathogenesis in Wild Animal Reservoirs and Captive Animal Models.Viruses. 2023;15:905. [DOI] [PubMed] [PMC]
Allan-Blitz LT, Klausner JD. Current Evidence Demonstrates That Monkeypox Is a Sexually Transmitted Infection.Sex Transm Dis. 2023;50:63–5. [DOI] [PubMed] [PMC]
Schwartz DA, Ha S, Dashraath P, Baud D, Pittman PR, Adams Waldorf KM. Mpox Virus in Pregnancy, the Placenta, and Newborn.Arch Pathol Lab Med. 2023;147:746–57. [DOI] [PubMed]
Sagdat K, Batyrkhan A, Kanayeva D. Exploring monkeypox virus proteins and rapid detection techniques.Front Cell Infect Microbiol. 2024;14:1414224. [DOI] [PubMed] [PMC]
Hosen MI, Mia ME, Islam MN, Khatun MUS, Emon TH, Hossain MA, et al. In-silico approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity.Antivir Ther. 2024;29:13596535241255199. [DOI] [PubMed]
Araf Y, Nipa JF, Naher S, Maliha ST, Rahman H, Arafat KI, et al. Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus.Vet Med Int. 2024;2024:8839830. [DOI] [PubMed] [PMC]
Schramm B, Locker JK. Cytoplasmic organization of POXvirus DNA replication.Traffic. 2005;6:839–46. [DOI] [PubMed]
Shi D, He P, Song Y, Cheng S, Linhardt RJ, Dordick JS, et al. Kinetic and Structural Aspects of Glycosaminoglycan-Monkeypox Virus Protein A29 Interactions Using Surface Plasmon Resonance.Molecules. 2022;27:5898. [DOI] [PubMed] [PMC]
Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, et al. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.Signal Transduct Target Ther. 2023;8:458. [DOI] [PubMed] [PMC]
Ortins-Pina A, Hegemann B, Saggini A, Deml KF, Wallerius K, Hörster S, et al. Histopathological features of human mpox: Report of two cases and review of the literature.J Cutan Pathol. 2023;50:706–10. [DOI] [PubMed]
Fang D, Liu Y, Dou D, Su B. The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies.Virol Sin. 2024;39:709–18. [DOI] [PubMed] [PMC]
Williams J, Bonner J, Kibler K, Jacobs BL. Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel?Adv Exp Med Biol. 2024;1451:125–37. [DOI] [PubMed]
Bordi L, D’Auria A, Frasca F, Mazzotta V, Mazzetti P, Fracella M, et al. MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effect.Med Microbiol Immunol. 2024;213:25. [DOI] [PubMed]
Xie CB, Jane-Wit D, Pober JS. Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets.Am J Pathol. 2020;190:1138–50. [DOI] [PubMed] [PMC]
Adamo S, Gao Y, Sekine T, Mily A, Wu J, Storgärd E, et al. Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.Cell Host Microbe. 2023;31:928–36.e4. [DOI] [PubMed] [PMC]
Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, et al. The land-scape of immune response to monkeypox virus.EBioMedicine. 2023;87:104424. [DOI] [PubMed] [PMC]
Wang Y, Wang Z, Li S, Ma J, Dai X, Lu J. Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions.Int Immunopharmacol. 2024;131:111846. [DOI] [PubMed]
Harapan H, Ophinni Y, Megawati D, Frediansyah A, Mamada SS, Salampe M, et al. Monkeypox: A Comprehensive Review.Viruses. 2022;14:2155. [DOI] [PubMed] [PMC]
Yi XM, Lei YL, Li M, Zhong L, Li S. The monkeypox virus-host interplays.Cell Insight. 2024;3:100185. [DOI] [PubMed] [PMC]
Yu C, Wu Q, Xin J, Yu Q, Ma Z, Xue M, et al. Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach.Microbiol Spectr. 2024;12:e00465-24. [DOI] [PubMed] [PMC]
Reus JB, Rex EA, Gammon DB. How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses.Pathogens. 2022;11:1061. [DOI] [PubMed] [PMC]
Huang Y, Bergant V, Grass V, Emslander Q, Hamad MS, Hubel P, et al. Multi-omics characterization of the monkeypox virus infection.Nat Commun. 2024;15:6778. [DOI] [PubMed] [PMC]
Li W, Zhuang Y, Shao SJ, Trivedi P, Zheng B, Huang GL, et al. Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID-19 (Review).Mol Med Rep. 2024;29:39. [DOI] [PubMed] [PMC]
Zhang R, Karijolich J. RNA recognition by PKR during DNA virus infection.J Med Virol. 2024;96:e29424. [DOI] [PubMed] [PMC]
Deng Y, Navarro-Forero S, Yang Z. Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes.mBio. 2025;16:e03809-24. [DOI] [PubMed] [PMC]
Morelli M, Madonna S, Albanesi C. SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation.Front Immunol. 2024;15:1393799. [DOI] [PubMed] [PMC]
Chan P, Ye ZW, Zhao W, Ong CP, Sun XY, Cheung PH, et al. Mpox virus poxin-schlafen fusion protein suppresses innate antiviral response by sequestering STAT2.Emerg Microbes Infect. 2025;14:2477639. [DOI] [PubMed] [PMC]
Mohammed Firdous S, Pal S. Role of Inflammatory and Growth Factors in Diabetes Mellitus.Palestinian Med Pharm J. 2024;9:193–212. [DOI]
Pashazadeh Azari P, Rezaei Zadeh Rukerd M, Charostad J, Bashash D, Farsiu N, Behzadi S, et al. Monkeypox (Mpox) vs. Innate immune responses: Insights into evasion mechanisms and potential therapeutic strategies.Cytokine. 2024;183:156751. [DOI] [PubMed]
Alakunle E, Kolawole D, Diaz-Cánova D, Alele F, Adegboye O, Moens U, et al. A comprehensive review of monkeypox virus and mpox characteristics.Front Cell Infect Microbiol. 2024;14:1360586. [DOI] [PubMed] [PMC]
Chen Y, Yue S, Yu L, Cao J, Liu Y, Deng A, et al. Regulation and Function of the cGAS-STING Pathway: Mechanisms, Post-Translational Modifications, and Therapeutic Potential in Immunotherapy.Drug Des Devel Ther. 2025;19:1721–39. [DOI] [PubMed] [PMC]
Eaglesham JB, Pan Y, Kupper TS, Kranzusch PJ. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling.Nature. 2019;566:259–63. [DOI] [PubMed] [PMC]
Li Q, Wu P, Du Q, Hanif U, Hu H, Li K. cGAS-STING, an important signaling pathway in diseases and their therapy.MedComm (2020). 2024;5:e511. [DOI] [PubMed] [PMC]
Lant S, Hood AJM, Holley JA, Ellis A, Eke L, Sumner RP, et al. Poxin-deficient poxviruses are sensed by cGAS prior to genome replication.J Gen Virol. 2024;105:002036. [DOI] [PubMed]
Qudus MS, Cui X, Tian M, Afaq U, Sajid M, Qureshi S, et al. The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology.Front Cell Infect Microbiol. 2023;13:1196699. [DOI] [PubMed] [PMC]
Cantu F, Cao S, Hernandez C, Dhungel P, Spradlin J, Yang Z. Poxvirus-encoded decapping enzymes promote selective translation of viral mRNAs.PLoS Pathog. 2020;16:e1008926. [DOI] [PubMed] [PMC]
Zandi M, Shafaati M, Hosseini F. Mechanisms of immune evasion of monkeypox virus.Front Microbiol. 2023;14:1106247. [DOI] [PubMed] [PMC]
Lum FM, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, Rénia L, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions.Nat Rev Immunol. 2022;22:597–613. [DOI] [PubMed] [PMC]
Liu Y, Wang M, Cheng A, Yang Q, Wu Y, Jia R, et al. The role of host eIF2α in viral infection.Virol J. 2020;17:112. [DOI] [PubMed] [PMC]
Gerlicki CM. Viral diseases affecting the skin.Dermatol Rev. 2024;5:e225. [DOI]
Ritter JM, Martines RB, Bhatnagar J, Rao AK, Villalba JA, Silva-Flannery L, et al.; Mpox Pathology Working Group. Pathology and Monkeypox virus Localization in Tissues From Immunocompromised Patients With Severe or Fatal Mpox.J Infect Dis. 2024;229:S219–28. [DOI] [PubMed]
Wei ZK, Zhao YC, Wang ZD, Sui LY, Zhao YH, Liu Q. Animal models of mpox virus infection and disease.Infect Med (Beijing). 2023;2:153–66. [DOI] [PubMed] [PMC]
Sepehrinezhad A, Ashayeri Ahmadabad R, Sahab-Negah S. Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives.J Neurol. 2023;270:101–8. [DOI] [PubMed] [PMC]
Yang Y, Niu S, Shen C, Yang L, Song S, Peng Y, et al. Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study.Nat Commun. 2024;15:4488. [DOI] [PubMed] [PMC]
Obermeier PE, Buder SC, Hillen U. Poxvirus infections in dermatology – the neglected, the notable, and the notorious.J Dtsch Dermatol Ges. 2024;22:56–93. [DOI] [PubMed]
Falco A, Adamek M, Pereiro P, Hoole D, Encinar JA, Novoa B, et al. The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases.Mar Drugs. 2022;20:363. [DOI] [PubMed] [PMC]
Gacesa R, Lawrence KP, Georgakopoulos ND, Yabe K, Dunlap WC, Barlow DJ, et al. The mycosporine-like amino acids porphyra-334 and shinorine are antioxidants and direct antagonists of Keap1-Nrf2 binding.Biochimie. 2018;154:35–44. [DOI] [PubMed] [PMC]
Punchakara A, Prajapat G, Bairwa HK, Jain S, Agrawal A. Applications of mycosporine-like amino acids beyond photoprotection.Appl Environ Microbiol. 2023;89:e00740-23. [DOI] [PubMed] [PMC]
He P, Shi D, Li Y, Xia K, Kim SB, Dwivedi R, et al. SPR Sensor-Based Analysis of the Inhibition of Marine Sulfated Glycans on Interactions between Monkeypox Virus Proteins and Glycosaminoglycans.Mar Drugs. 2023;21:264. [DOI] [PubMed] [PMC]
Yi M, Lin S, Zhang B, Jin H, Ding L. Antiviral potential of natural products from marine microbes.Eur J Med Chem. 2020;207:112790. [DOI] [PubMed] [PMC]
Fathi F, Hosseinabadi T, Faraji A, Tabarzad M. Different sources of mycosporine-like amino acids: Natural, heterologous expression, and chemical synthesis/modifications.Future Nat Prod. 2022;8:78–85. [DOI]
Peng J, Guo F, Liu S, Fang H, Xu Z, Wang T. Recent Advances and Future Prospects of Mycosporine-like Amino Acids.Molecules. 2023;28:5588. [DOI] [PubMed] [PMC]
Becker K, Hartmann A, Ganzera M, Fuchs D, Gostner JM. Immunomodulatory Effects of the Mycosporine-Like Amino Acids Shinorine and Porphyra-334.Mar Drugs. 2016;14:119. [DOI] [PubMed] [PMC]
Rosic NN. Mycosporine-Like Amino Acids: Making the Foundation for Organic Personalised Sunscreens.Mar Drugs. 2019;17:638. [DOI] [PubMed] [PMC]
Rogero MM, Leão MC, Santana TM, Pimentel MVMB, Carlini GCG, da Silveira TFF, et al. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.Free Radic Biol Med. 2020;156:190–9. [DOI] [PubMed] [PMC]
Bhattacharyya S, Liu H, Zhang Z, Jam M, Dudeja PK, Michel G, et al. Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds.J Nutr Biochem. 2010;21:906–13. [DOI] [PubMed] [PMC]
Martino JV, Van Limbergen J, Cahill LE. The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation.Front Pediatr. 2017;5:96. [DOI] [PubMed] [PMC]
Luo M, Shao B, Nie W, Wei XW, Li YL, Wang BL, et al. Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy.Sci Rep. 2015;5:11062. [DOI] [PubMed] [PMC]
Nguyen-Contant P, Sangster MY, Topham DJ. Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response.Pathogens. 2021;10:355. [DOI] [PubMed] [PMC]
Ebrahimi M, Farhadian N, Soflaei SS, Amiri A, Tanbakuchi D, Oskooee RK, et al. Utilizing the sublingual form of squalene in COVID-19 patients: a randomized clinical trial.Sci Rep. 2024;14:4532. [DOI] [PubMed] [PMC]
Apostolova E, Lukova P, Baldzhieva A, Katsarov P, Nikolova M, Iliev I, et al. Immunomodulatory and Anti-Inflammatory Effects of Fucoidan: A Review.Polymers (Basel). 2020;12:2338. [DOI] [PubMed] [PMC]
Zhang W, Oda T, Yu Q, Jin JO. Fucoidan from Macrocystis pyrifera has powerful immune-modulatory effects compared to three other fucoidans.Mar Drugs. 2015;13:1084–104. [DOI] [PubMed] [PMC]
Lusvarghi S, Bewley CA. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.Viruses. 2016;8:296. [DOI] [PubMed] [PMC]
Reynolds D, Huesemann M, Edmundson S, Sims A, Hurst B, Cady S, et al. Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.Algal Res. 2021;57:102331. [DOI] [PubMed] [PMC]
Wang Y, Ye L, Yan R, Guo C, Mu M, Sun Y, et al. Ilex asprella-derived polysaccharide activates macrophage via TLR4-mediated NF-κB and MAPK signaling pathways.J Funct Foods. 2024;122:106527. [DOI]
Choi S, Jeon SA, Heo BY, Kang JG, Jung Y, Duong PTT, et al. Gene Set Enrichment Analysis Reveals That Fucoidan Induces Type I IFN Pathways in BMDC.Nutrients. 2022;14:2242. [DOI] [PubMed] [PMC]
Sukmarini L. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.Molecules. 2022;27:2619. [DOI] [PubMed] [PMC]
Leopold-Messer S, Chepkirui C, Mabesoone MFJ, Meyer J, Paoli L, Sunagawa S, et al. Animal-associated marine Acidobacteria with a rich natural-product repertoire.Chem. 2023;9:3696–713. [DOI]
Bowling JJ, Kochanowska AJ, Kasanah N, Hamann MT. Nature’s bounty – drug discovery from the sea.Expert Opin Drug Discov. 2007;2:1505–22. [DOI] [PubMed] [PMC]
Leal MC, Sheridan C, Osinga R, Dionísio G, Rocha RJM, Silva B, et al. Marine microorganism-invertebrate assemblages: perspectives to solve the “supply problem” in the initial steps of drug discovery.Mar Drugs. 2014;12:3929–52. [DOI] [PubMed] [PMC]
Zhou Q, Hotta K, Deng Y, Yuan R, Quan S, Chen X. Advances in Biosynthesis of Natural Products from Marine Microorganisms.Microorganisms. 2021;9:2551. [DOI] [PubMed] [PMC]
Gricourt G, Meyer P, Duigou T, Faulon JL. Artificial Intelligence Methods and Models for Retro-Biosynthesis: A Scoping Review.ACS Synth Biol. 2024;13:2276–94. [DOI] [PubMed] [PMC]
Wang X, Lin P, Shen Q, Feng X, Xu S, Zhang Q, et al. A highly efficient heterologous expression platform to facilitate the production of microbial natural products in Streptomyces.Microb Cell Fact. 2025;24:105. [DOI] [PubMed] [PMC]
Morokutti-Kurz M, Fröba M, Graf P, Große M, Grassauer A, Auth J, et al. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.PLoS One. 2021;16:e0237480. [DOI] [PubMed] [PMC]
Lomartire S, Gonçalves AMM. Antiviral Activity and Mechanisms of Seaweeds Bioactive Compounds on Enveloped Viruses—A Review.Mar Drugs. 2022;20:385. [DOI] [PubMed] [PMC]
Obiedallah MM, Melekhin VV, Menzorova YA, Bulya ET, Minin AS, Mironov MA. Fucoidan coated liposomes loaded with novel antituberculosis agent: preparation, evaluation, and cytotoxicity study.Pharm Dev Technol. 2024;29:311–21. [DOI] [PubMed]
Ali M, Kim W, Park J. Droplet microfluidic technologies for next-generation high-throughput screening.Front Lab Chip Technol. 2023;2:1230791. [DOI]
